BIG PHARMAS, NOT SUCH AN ALL-WEATHER INVESTMENT
25/06/20 -"This story was first issued on 15-06-2020. ‘Valuation Wise’ takes a rest. Pre-COVID-19, holding Big Pharmas (seven issuers, €940bn market cap) would not make a big difference ..."
Pages
62
Language
English
Published on
25/06/20
You may also be interested by these reports :
02/09/26
BARC (Reduce; UK) is posting one of the sector’s worst performances year-to-date, despite a supportive market environment. The stock is up by only 6% ...
02/09/26
One wonders what could trip up European Banks. The 37 banks under coverage by AlphaValue have gained 23% ytd and have easily outperformed the ...
01/09/26
We have decided to revisit our complacent valuation to align our recommendation with our fundamental sentiment that the stock should continue to ...
25/08/26
We have updated our projections on SocGen, upgrading our 2026 projections (+10%), but downgrading our 2027 estimates (-17%). For 2026, our upgrade ...